Replies to post #232584 on Liquidmetal Technologies Inc (LQMT)

[chipboarder]

BP monitoring can be very difficult….I can’t get my right arm to duplicate my left. At the doctor’s office, I sit in a straight backed chair, uncross my legs, keep the measuring device at roughly the level of my heart and refrain from talking….by the way DON’T MOVE.

If that protocol is the baseline and one expects to get a reliable reading from a person who is going about daily activities, I’ll bet getting into the FDA guidelines/expectations is a huge hurdle. You almost have to take multiple (>10) readings and do some pretty sophisticated smoothing. Erratic readings need to be dealt with…maybe an average with some indication of confidence limits.

If a person has orthostatic hypotension, the act of standing up can cause their systolic BP to drop 20mm and recover in a few seconds….big challenge.

[Researchfyi]

“You didn’t mention glucose monitoring and whether the timing is sooner or later than BP. “

I didn’t have to. They are not doing it. They are looking into a wristband for both BP and glucose. Their attempt at adding BP to the ring are years away for trials and FDA approval.

The focus on their success right now depends on women and FDA approval to increase demand. If their apps are too difficult to function and also still limited to iOS, then they have more kinks to iron out. It’s a start up company. The way things work out is when they start getting real feed back from the women who are now wearing the ring.

In essence the real trial has just begun and it takes about three months of data to get a better understanding to use the ring for the purpose it was sold.

I do not own any stock in movano.

If you have any doubts about what I posted, feel free to contact them. I may have misunderstood some of the comments made by the executives at movano regarding their business plans for the future. EOS.